{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T22:18:03Z","timestamp":1759702683198},"reference-count":36,"publisher":"Wiley","issue":"S642","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":10695,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[1980,1,12]]},"abstract":"<jats:p><jats:bold>ABSTRACT. <\/jats:bold> Platelet function, intra\u2010vascular coagulation (IVC) and fibrinolysis were studied in 85 patients with Type II hyperlipo\u2010proteinaemia, 36 with Type IV hypertriglyce\u2010ridaemia and 36 normal subjects. The effects of clofibrate and nicotinic acid therapy on their plasma lipid concentrations, platelet behaviour, IVC and fibrinolysis were also evaluated. Untreated Type II patients had platelet hyperreactivity to aggregating agents and increased nucleotide release. Their platelet phospholipid content was quantitatively and qualitatively altered. The mechanism of platelet hyperreactivity appears to be related to their ability to convert AA to cyclic endoperoxides and thromboxanes. Although both groups of common hyperlipidaemias had accelerated activation of the blood coagulation systems, the Type II patients had worse blood alterations than the Type IV patients did. Furthermore, our data also suggests that in hypercholesterolaemia platelets appear to mediate these blood changes. Clofibrate treatment in Type II patients improved the platelet reactivity, reversed IVC and stimulated fibrinolysis without altering their plasma lipid levels. In contrast, in Type IV patients, clofibrate therapy significantly lowered plasma triglycerides but did not alter the blood coagulation changes nor did it stimulate fibrinolysis. Thrombo\u2010embolic complications were common in both groups of hyperlipida etnias but more so in Type II patients. A correlation therefore appears to exist between laboratory evidence of platelet reactivity and IVC and increased incidence of thromboembolic complications.<\/jats:p><jats:p>Taken together, these observations suggest that anti\u2010platelet drugs may be useful in the prevention of thrombo\u2010embolic complications in Type II patients. In contrast, in hypertriglyceridaemia, impairment of the fibrinolytic system is the likely mechanism by which these thrombotic events occur. Unfortunately, simple preventive treatments to stimulate fibrinolysis are not yet available.<\/jats:p>","DOI":"10.1111\/j.0954-6820.1980.tb10941.x","type":"journal-article","created":{"date-parts":[[2010,8,15]],"date-time":"2010-08-15T18:03:18Z","timestamp":1281895398000},"page":"101-112","source":"Crossref","is-referenced-by-count":11,"title":["Platelets, Intravascular Coagulation and Fibrinolysis in Hyperlipidaemias: Relationship to Thrombo\u2010Embolic Complications"],"prefix":"10.1111","volume":"208","author":[{"given":"Angelina C. A.","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_2_2_2","unstructured":"Aviram M. Lees A. M.&Lees R. S.: (manuscript in preparation) 1980."},{"key":"e_1_2_2_3_2","first-page":"311","article-title":"Uber die Retraktion des Blut\u2010gerinnsels:","volume":"3","author":"Benthaus J.","year":"1959","journal-title":"Thromb Diath Haemorrh (Stuttg)."},{"key":"e_1_2_2_4_2","first-page":"228","article-title":"Platelet prostaglandin endoperoxide formation in hyperlipidaemias","volume":"38","author":"Bizios R.","year":"1977","journal-title":"Thromb Haemost"},{"key":"e_1_2_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/194927b0"},{"key":"e_1_2_2_6_2","volume-title":"Fibrinolysis. Standardized fibrin plate method and fibrinolytic assay of plasminogen","author":"Brakman P.","year":"1967"},{"key":"e_1_2_2_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197402212900805"},{"key":"e_1_2_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(76)90013-X"},{"key":"e_1_2_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.50.3.570"},{"key":"e_1_2_2_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.56.1.114"},{"key":"e_1_2_2_11_2","first-page":"117","article-title":"Activation of the kallikrein system in hyperbetalipoproteinemia","volume":"91","author":"Carvalho A. C.","year":"1978","journal-title":"J Lab Clin Med."},{"key":"e_1_2_2_12_2","unstructured":"Carvalho A. C. Brook G. J.&Lees R. S.: (submitted for publication) 1980."},{"key":"e_1_2_2_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-71-4-763"},{"key":"e_1_2_2_14_2","first-page":"159","article-title":"Blood hypercoagulability and thrombosos","volume":"83","author":"Fletcher A. P.","year":"1970","journal-title":"Trans Assoc Am Phys."},{"key":"e_1_2_2_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.8.2994"},{"key":"e_1_2_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4831-9942-9.50008-5"},{"key":"e_1_2_2_17_2","first-page":"93","article-title":"Measurement of fibrinogen and fibrinogen degradation products in serum by staphylococcal clumping test","volume":"75","author":"Hawiger J.","year":"1970","journal-title":"J Lab Clin Med"},{"key":"e_1_2_2_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/282210a0"},{"key":"e_1_2_2_19_2","first-page":"413","article-title":"Some effects of fibrinogen degradation products on blood platelets","volume":"15","author":"Jerushalmy Z.","year":"1966","journal-title":"Thromb Diath Haemmorh (Stuttg)"},{"key":"e_1_2_2_20_2","first-page":"237","article-title":"The familial dyslipoproteinemias","volume":"9","author":"Lees R. S.","year":"1973","journal-title":"Prog Med Genet"},{"key":"e_1_2_2_21_2","first-page":"518","article-title":"Sharper separation of lipoprotein species by paper electrophoresis in albumin\u2010containing buffer","volume":"61","author":"Lees R. S.","year":"1973","journal-title":"J Lab Clin Med"},{"key":"e_1_2_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0019-2791(65)90004-2"},{"key":"e_1_2_2_23_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1960.sp006434"},{"key":"e_1_2_2_24_2","first-page":"325","article-title":"The role of Hageman factor in disseminated intravascular coagulation by septicemia, neoplasia or liver disease","volume":"26","author":"Mason J. W.","year":"1971","journal-title":"Thromb Diath Haemmorh (Stuttg)"},{"key":"e_1_2_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-6980(76)90048-4"},{"key":"e_1_2_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1971.tb04395.x"},{"key":"e_1_2_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/36.3.212"},{"key":"e_1_2_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/15.12.560"},{"key":"e_1_2_2_29_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105782"},{"key":"e_1_2_2_30_2","unstructured":"Raymond T.&Lees R. S.: (manuscript in preparation) 1980."},{"key":"e_1_2_2_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.4.1207"},{"key":"e_1_2_2_32_2","first-page":"724","article-title":"Measurement of platelet adhesiveness: a simple in vitro technique demonstrating an abnormality in von Willebrand's disease","volume":"62","author":"Salzman E. W.","year":"1963","journal-title":"J Lab Clin Med"},{"key":"e_1_2_2_33_2","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2275(20)39797-2","article-title":"Platelet function and platelet lipid composition in dyslipoproteinemias","author":"Shastri K.","year":"1980","journal-title":"J Lipid Res"},{"key":"e_1_2_2_34_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107971"},{"key":"e_1_2_2_35_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj0900374"},{"key":"e_1_2_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)90101-6"},{"key":"e_1_2_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(70)90478-X"}],"container-title":["Acta Medica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0954-6820.1980.tb10941.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0954-6820.1980.tb10941.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T23:38:10Z","timestamp":1699832290000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0954-6820.1980.tb10941.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,1,12]]},"references-count":36,"journal-issue":{"issue":"S642","published-print":{"date-parts":[[1980,1,12]]}},"alternative-id":["10.1111\/j.0954-6820.1980.tb10941.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0954-6820.1980.tb10941.x","archive":["Portico"],"relation":{},"ISSN":["0001-6101"],"issn-type":[{"value":"0001-6101","type":"print"}],"subject":[],"published":{"date-parts":[[1980,1,12]]}}}